Brorson J R, Marcuccilli C J, Miller R J
Department of Neurology, University of Chicago Ill 60637, USA.
Stroke. 1995 Jul;26(7):1259-66; discussion 1267. doi: 10.1161/01.str.26.7.1259.
Glutamate receptor antagonists can produce protection against the neurotoxicity of excessive glutamate stimulation. However, antagonism of the postreceptor processes that produce cell damage may provide a longer window of opportunity for protecting neurons after the initiation of excitotoxic injury. Among various processes that have been thought to mediate the toxic effects of glutamate are activation of the Ca(2+)-dependent proteases calpain I and II and the activation of nitric oxide synthase. We tested the potential for neuroprotection by delayed application of calpain antagonists after excitotoxic treatment.
Primary cultures of cerebellar and hippocampal neurons were exposed to the glutamate receptor agonists kainate and N-methyl-D-aspartate (NMDA) for 20-minute periods, and survival was examined by fluorescent assay after 24 hours. Enzyme antagonists were applied at various time points during this interval.
The neurotoxic effects of NMDA in cultured hippocampal neurons and of kainate in cultured cerebellar neurons have been previously shown to be Ca2+ dependent. Here we show that in both of these examples of glutamate receptor-mediated toxicity, activation of a calpainlike proteolytic activity occurred, which was blocked by the calpain inhibitor MDL-28170. This inhibitor also limited the toxicity, even when applied at times up to 1 hour after the onset of the toxic exposure. Another protease inhibitor, E-64, also blocked the proteolysis and toxicity produced by kainate in cerebellar neurons. Blocking nitric oxide synthase activity after 1 hour with the antagonist NG-nitro-L-arginine was also protective of cerebellar and hippocampal neurons, as was the combination of MDL-28170 and NG-nitro-L-arginine.
The activation of calpain is among several enzymatic processes that contribute to the toxicity of glutamate receptor stimulation, and blocking these postreceptor mechanisms can be effective in protecting neurons from excitotoxicity at delayed time points.
谷氨酸受体拮抗剂可对过量谷氨酸刺激所致的神经毒性产生保护作用。然而,拮抗产生细胞损伤的受体后过程可能会在兴奋性毒性损伤开始后为保护神经元提供更长的机会窗口。在众多被认为介导谷氨酸毒性作用的过程中,包括依赖钙离子的蛋白酶钙蛋白酶I和II的激活以及一氧化氮合酶的激活。我们测试了兴奋性毒性处理后延迟应用钙蛋白酶拮抗剂的神经保护潜力。
将小脑和海马神经元的原代培养物暴露于谷氨酸受体激动剂海藻酸和N-甲基-D-天冬氨酸(NMDA)20分钟,24小时后通过荧光测定法检测细胞存活情况。在此期间的不同时间点应用酶拮抗剂。
先前已表明,NMDA对培养的海马神经元的神经毒性作用以及海藻酸对培养的小脑神经元的神经毒性作用均依赖钙离子。在此我们表明,在这两个谷氨酸受体介导的毒性实例中,均发生了类似钙蛋白酶的蛋白水解活性的激活,其可被钙蛋白酶抑制剂MDL-28170阻断。即使在毒性暴露开始后长达1小时应用该抑制剂,其也能限制毒性。另一种蛋白酶抑制剂E-64也可阻断海藻酸在小脑神经元中产生的蛋白水解和毒性作用。用拮抗剂NG-硝基-L-精氨酸在1小时后阻断一氧化氮合酶活性对小脑和海马神经元也具有保护作用,MDL-28170与NG-硝基-L-精氨酸联合应用同样如此。
钙蛋白酶的激活是导致谷氨酸受体刺激毒性的几种酶促过程之一,阻断这些受体后机制可有效在延迟时间点保护神经元免受兴奋性毒性作用。